Review

• DIRECTION TO REACH CLOSER TO THE EFFECTIVE LABELING OF DRUGS WITH CRITICAL PARAMETERS

  Dipak Kumar Mal, Mondal Laboni, Biswajit Mukherjee

  Pages 1-7

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v3i3.166
• COMPARISON OF GLOBAL REGULATORY GUIDELINES FOR AVAILABILITY OF DIFFERENT BIOWAIVER PROVISIONS AND APPLICATION REQUIREMENTS OF BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) BASED BIOWAIVER.

  Jimi Patel, Priti Mehta, Vaishali Kothari

  Pages 8-20

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v3i3.167
• DRUG REGULATION IN INDIA: SWOT ANALYSIS

  Priyanka V. Patel

  Pages 21-27

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v3i3.168
• PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DESIGN OF QUALITY CONTROL GUIDLINES FOR PROBIOTICS

  Neetu Singh, Manish Gupta

  Pages 28-35

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v3i3.169
• CRITICAL SURVEY ON THE GUIDELINES UNDER RECOMMENDATION OF CHILD RESISTANT PACKAGING FOR PHARMACEUTICAL PRODUCTS

  Sangeeta Singh, Manish Gupta

  Pages 36-41

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v3i3.170